Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Alper Sevinç1 Department of Medical Oncology, Medical Park Gaziantep Hospital, GaziantepCorrespondence[email protected]

Metin Özkan2 Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri

Ahmet Özet3 Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara

Faysal Dane4 Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul

Berna Öksüzoğlu5 Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara

Abdurrahman Işıkdoğan6 Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakır

Feyyaz Özdemir7 Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon

Doğan Uncu8 Department of Medical Oncology, Ankara Numune Hospital, Ankara

Mahmut Gümüş9 Department of Medical Oncology, Istanbul Medeniyet University, Istanbul

Türkkan Evrensel10 Department of Medical Oncology, Uludağ University Faculty of Medicine, Bursa

Arzu Yaren11 Department of Medical Oncology, Pamukkale University Faculty of Medicine, Denizli

Oğuz Kara12 Department of Medical Oncology, Çukurova University Faculty of Medicine, Adana

Salim Başol Tekin13 Department of Medical Oncology, Atatürk University Faculty of Medicine, Erzurum, Turkey

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.